City Center Advisors, LLC Catalyst Pharmaceuticals, Inc. Transaction History
City Center Advisors, LLC
- $103 Billion
- Q3 2025
A detailed history of City Center Advisors, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, City Center Advisors, LLC holds 12,878 shares of CPRX stock, worth $262,196. This represents 0.25% of its overall portfolio holdings.
Number of Shares
12,878Holding current value
$262,196% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
387Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$381 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$178 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$112 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.2 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$64.8 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.09B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...